Rapid Micro Biosystems, Inc. (RPID)
NASDAQ: RPID · IEX Real-Time Price · USD
0.670
-0.015 (-2.19%)
Jul 26, 2024, 3:39 PM EDT - Market closed
Rapid Micro Biosystems Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year Ending | TTM | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 |
|---|---|---|---|---|---|---|
| Revenue | 23.1 | 22.52 | 17.13 | 23.23 | 16.08 | 16.51 |
| Revenue Growth (YoY) | 28.25% | 31.44% | -26.25% | 44.50% | -2.63% | - |
| Cost of Revenue | 28.31 | 28 | 25.67 | 30.97 | 24.15 | 16.75 |
| Gross Profit | -5.22 | -5.49 | -8.54 | -7.74 | -8.07 | -0.23 |
| Selling, General & Admin | 37.24 | 38.26 | 41.81 | 29.71 | 15.94 | 12.97 |
| Research & Development | 13.51 | 12.82 | 12.87 | 9.78 | 6.53 | 5.43 |
| Operating Expenses | 50.75 | 51.08 | 54.68 | 39.49 | 22.47 | 18.4 |
| Operating Income | -55.96 | -56.56 | -63.22 | -47.23 | -30.54 | -18.63 |
| Interest Expense | - | - | - | -2.61 | -3.45 | -2.38 |
| Interest & Investment Income | 4.19 | 4.21 | 1.78 | - | - | - |
| Other Non Operating Income (Expenses) | -0.1 | -0.08 | 0.06 | -19.64 | -0.05 | 0.27 |
| EBT Excluding Unusual Items | -51.88 | -52.44 | -61.38 | -69.48 | -34.03 | -20.74 |
| Other Unusual Items | - | - | - | -3.95 | -2.91 | - |
| Pretax Income | -51.88 | -52.44 | -61.38 | -73.43 | -36.94 | -20.74 |
| Income Tax Expense | 0.03 | 0.03 | -0.58 | 0.09 | 0.13 | 0.43 |
| Net Income | -51.9 | -52.47 | -60.81 | -73.52 | -37.08 | -21.17 |
| Preferred Dividends & Other Adjustments | - | - | - | 4.51 | 8.14 | 5.45 |
| Net Income to Common | -51.9 | -52.47 | -60.81 | -78.03 | -45.22 | -26.62 |
| Shares Outstanding (Basic) | 43 | 43 | 42 | 20 | 0 | 0 |
| Shares Outstanding (Diluted) | 43 | 43 | 42 | 20 | 0 | 0 |
| Shares Change (YoY) | 1.23% | 1.34% | 114.59% | 5417.16% | 3.34% | - |
| EPS (Basic) | -1.20 | -1.22 | -1.43 | -3.94 | -126.11 | -76.72 |
| EPS (Diluted) | -1.20 | -1.22 | -1.43 | -3.94 | -126.11 | -76.72 |
| Free Cash Flow | -45.59 | -46.93 | -65.29 | -58.18 | -31.69 | -22.84 |
| Free Cash Flow Per Share | -1.06 | -1.09 | -1.54 | -2.94 | -88.36 | -65.83 |
| Gross Margin | -22.59% | -24.36% | -49.85% | -33.32% | -50.20% | -1.42% |
| Operating Margin | -242.32% | -251.18% | -368.99% | -203.31% | -189.96% | -112.85% |
| Profit Margin | -224.73% | -232.99% | - | - | -230.63% | -128.22% |
| Free Cash Flow Margin | -197.41% | -208.38% | -381.06% | -250.43% | -197.09% | -138.34% |
| EBITDA | -53.11 | -53.76 | -60.68 | -45.8 | -29.03 | -17.17 |
| EBITDA Margin | -229.97% | -238.72% | - | -197.15% | -180.57% | -104.01% |
| D&A For EBITDA | 2.85 | 2.81 | 2.54 | 1.43 | 1.51 | 1.46 |
| EBIT | -55.96 | -56.56 | -63.22 | -47.23 | -30.54 | -18.63 |
| EBIT Margin | -242.32% | -251.18% | - | -203.31% | -189.96% | -112.85% |
| Revenue as Reported | 23.1 | 22.52 | 17.13 | 23.23 | 16.08 | 16.51 |
| Advertising Expenses | - | 0.3 | 0.1 | 0.1 | 0.1 | 0.1 |
Source: S&P Capital IQ. Standard template.